Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 7/2017

08.02.2017 | Clinical Investigation

Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts

verfasst von: Amar Mukund, Ganesh Deogaonkar, S. Rajesh, Saggerre Muralikrishna Shasthry, Shiv Kumar Sarin

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the safety and efficacy sodium tetradecyl sulfate and lipiodol foam (STS foam) in BRTO for large (caliber ≥15 mm) porto-systemic shunt and gastric fundal varices.

Materials and Methods

It is a retrospective record-based study of patients who underwent BRTO using STS foam at the Institute of Liver and Biliary Sciences, New Delhi, for gastric variceal bleed or refractory hepatic encephalopathy (HE) who had large porto-systemic shunt (diameter ≥15 mm) with or without associated gastric varices. Clinical and laboratory parameters were evaluated before and after the procedure. All patients were followed for minimum of 12 months.

Results

Records of 22 patients were analyzed. Technical success was achieved in 22 of 22 sessions. Complete obliteration of shunt with clinical improvement was seen in 20 of 22 cases. Patients with gastric varices had no residual gastric varices on follow-up endoscopy. There were significant reduction in CTP scores and improvement in HE grades following BRTO. Post-procedure complication was encountered in 6 patients (5 minor and 1 major), and 7 patients showed worsening of esophageal varices and underwent endoscopic variceal ligation. One patient had succumbed to septicemia at a follow-up of 34 months.

Conclusion

Our experience suggests STS foam is a safe and effective agent for patients with large shunt undergoing BRTO.
Literatur
2.
Zurück zum Zitat Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–8.CrossRefPubMed Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–8.CrossRefPubMed
3.
Zurück zum Zitat Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR. 2004;183:369–76.CrossRefPubMed Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR. 2004;183:369–76.CrossRefPubMed
4.
Zurück zum Zitat Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349–56.CrossRefPubMed Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349–56.CrossRefPubMed
5.
Zurück zum Zitat Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR. 1996;167:1317–20.CrossRefPubMed Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR. 1996;167:1317–20.CrossRefPubMed
6.
Zurück zum Zitat Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010;27(4):391–9.CrossRef Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010;27(4):391–9.CrossRef
7.
Zurück zum Zitat Dietzek CL. Sclerotherapy: introduction to solutions and techniques. Perspect Vasc Surg Endovasc Ther. 2007;19(3):317–24.CrossRefPubMed Dietzek CL. Sclerotherapy: introduction to solutions and techniques. Perspect Vasc Surg Endovasc Ther. 2007;19(3):317–24.CrossRefPubMed
8.
Zurück zum Zitat Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Semin Interv Radiol. 2008;25(3):204–15.CrossRef Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Semin Interv Radiol. 2008;25(3):204–15.CrossRef
9.
Zurück zum Zitat Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011;22:309–16.CrossRefPubMed Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011;22:309–16.CrossRefPubMed
10.
Zurück zum Zitat Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.CrossRefPubMed Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.CrossRefPubMed
11.
Zurück zum Zitat Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–202.CrossRefPubMed Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–202.CrossRefPubMed
12.
Zurück zum Zitat Gandini R, Konda D, Reale CA, et al. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate—outcome in 244 patients. Radiology. 2008;246:612–8.CrossRefPubMed Gandini R, Konda D, Reale CA, et al. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate—outcome in 244 patients. Radiology. 2008;246:612–8.CrossRefPubMed
13.
Zurück zum Zitat Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high-risk gastric fundal varices. Am J Gastroenterol. 1999;94:643–9.CrossRefPubMed Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high-risk gastric fundal varices. Am J Gastroenterol. 1999;94:643–9.CrossRefPubMed
14.
Zurück zum Zitat Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–36.CrossRefPubMed Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–36.CrossRefPubMed
15.
Zurück zum Zitat Kato T, Uematu T, Nishigaki Y, et al. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Intern Med. 2001;40:688–91.CrossRefPubMed Kato T, Uematu T, Nishigaki Y, et al. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Intern Med. 2001;40:688–91.CrossRefPubMed
16.
Zurück zum Zitat Ninoi T, Nishida N, Kaminou T, et al. Balloon- occluded retrograde Transvenous obliteration of gastric varices with gastro-renal shunt: long-term follow-up in 78 patients. Am J Roentgenol. 2005;184(4):1340–6.CrossRef Ninoi T, Nishida N, Kaminou T, et al. Balloon- occluded retrograde Transvenous obliteration of gastric varices with gastro-renal shunt: long-term follow-up in 78 patients. Am J Roentgenol. 2005;184(4):1340–6.CrossRef
17.
Zurück zum Zitat Takashimizu S, Watanabe N, Kojima S, et al. Efficacy of balloon occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt. Tokai J Exp Clin Med. 2007;32:70–4.PubMed Takashimizu S, Watanabe N, Kojima S, et al. Efficacy of balloon occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt. Tokai J Exp Clin Med. 2007;32:70–4.PubMed
18.
Zurück zum Zitat Sherif SH, Robert SS, Michael JH, et al. Reversal of hepatic encephalopathy after occlusion of total portosystemic shunts. Am J Surg. 1981;142:285–9.CrossRef Sherif SH, Robert SS, Michael JH, et al. Reversal of hepatic encephalopathy after occlusion of total portosystemic shunts. Am J Surg. 1981;142:285–9.CrossRef
19.
Zurück zum Zitat Hiraoka A, Kurose K, Hamada M, et al. Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by interventional radiology. Intern Med. 2005;44:212–6.CrossRefPubMed Hiraoka A, Kurose K, Hamada M, et al. Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by interventional radiology. Intern Med. 2005;44:212–6.CrossRefPubMed
20.
Zurück zum Zitat Mukund A, Rajesh S, Arora A, et al. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol. 2012;23:1200–6.CrossRefPubMed Mukund A, Rajesh S, Arora A, et al. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol. 2012;23:1200–6.CrossRefPubMed
21.
Zurück zum Zitat Akahane T, Iwasaki T, Kobayashi N, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol. 1997;92:1026–30.PubMed Akahane T, Iwasaki T, Kobayashi N, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol. 1997;92:1026–30.PubMed
22.
Zurück zum Zitat Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001;129:414–20.CrossRefPubMed Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001;129:414–20.CrossRefPubMed
23.
Zurück zum Zitat Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR. 2002;178:1167–74.CrossRefPubMed Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR. 2002;178:1167–74.CrossRefPubMed
24.
Zurück zum Zitat Cardoso J, Gautreau C, Jeyaraji PR, et al. Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology. 1994;19:375–80.CrossRefPubMed Cardoso J, Gautreau C, Jeyaraji PR, et al. Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology. 1994;19:375–80.CrossRefPubMed
25.
Zurück zum Zitat Miyamoto Y, Oho K, Kumamoto M, et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol. 2003;18:934–42.CrossRefPubMed Miyamoto Y, Oho K, Kumamoto M, et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol. 2003;18:934–42.CrossRefPubMed
26.
Zurück zum Zitat Yamagami T, Kato T, Iida S, Tanaka O, Nishimura T. Change in the hemodynamics of the portal venous system after retrograde transvenous balloon occlusion of a gastrorenal shunt. AJR. 2003;181:1011–5.CrossRefPubMed Yamagami T, Kato T, Iida S, Tanaka O, Nishimura T. Change in the hemodynamics of the portal venous system after retrograde transvenous balloon occlusion of a gastrorenal shunt. AJR. 2003;181:1011–5.CrossRefPubMed
27.
Zurück zum Zitat Kumamoto M, Toyonaga A, Inoue H, et al. Long term results of balloon- occluded retrograde transvenous obliteration for gastric varices: hepatic deterioration links to porto-systemic shunt syndrome. J Gastroenterol Hepatol. 2010;25(6):1129–35.CrossRefPubMed Kumamoto M, Toyonaga A, Inoue H, et al. Long term results of balloon- occluded retrograde transvenous obliteration for gastric varices: hepatic deterioration links to porto-systemic shunt syndrome. J Gastroenterol Hepatol. 2010;25(6):1129–35.CrossRefPubMed
28.
Zurück zum Zitat Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, et al. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration. J Hepatob Pancreat Sci. 2010;17:898–903.CrossRef Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, et al. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration. J Hepatob Pancreat Sci. 2010;17:898–903.CrossRef
29.
Zurück zum Zitat Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702–9.CrossRefPubMed Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702–9.CrossRefPubMed
Metadaten
Titel
Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts
verfasst von
Amar Mukund
Ganesh Deogaonkar
S. Rajesh
Saggerre Muralikrishna Shasthry
Shiv Kumar Sarin
Publikationsdatum
08.02.2017
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 7/2017
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1593-5

Weitere Artikel der Ausgabe 7/2017

CardioVascular and Interventional Radiology 7/2017 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.